{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:39:24Z","timestamp":1791308364314,"version":"4.3.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.det.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T13:54:58Z","timestamp":1113486898000},"page":"209-226","source":"Crossref","is-referenced-by-count":78,"title":["Melanin Pigmentary Disorders: Treatment Update"],"prefix":"10.1016","volume":"23","author":[{"given":"Jean-Paul","family":"Ortonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2005.01.001_bib1","series-title":"The pigmentary system: physiology and physiopathology","author":"Ortonne","year":"1998"},{"key":"10.1016\/j.det.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0738-081X(03)00045-2","article-title":"The treatment of hypopigmentation in children","volume":"21","author":"Schaffer","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0738-081X(97)00133-8","article-title":"Psoralen photochemotherapy for vitiligo","volume":"15","author":"Grimes","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib5","first-page":"1022","article-title":"Phototherapy with UV-B in vitiligo","volume":"65","author":"Koster","year":"1990","journal-title":"Z Hautkr"},{"key":"10.1016\/j.det.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-0781.2001.170403.x","article-title":"PUVA and PUVB in vitiligo: are they equally effective?","volume":"17","author":"Mofty","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.det.2005.01.001_bib7","series-title":"Dermatology, vol. I, chapter 66","first-page":"947","article-title":"Vitiligo and other disorders of hypopigmentation","author":"Ortonne","year":"2003"},{"key":"10.1016\/j.det.2005.01.001_bib8","series-title":"The pigmentary system. chapter 37","first-page":"513","article-title":"Vitiligo vulgaris","author":"Nordlund","year":"1998"},{"key":"10.1016\/j.det.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1468-3083.1999.tb00861.x","article-title":"UV-B radiation microphototherapy: an elective treatment for segmental vitiligo","volume":"13","author":"Lotti","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1468-3083.2003.00743.x","article-title":"Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo","volume":"17","author":"Menchini","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-3083.2003.00818.x","article-title":"Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study","volume":"17","author":"Leone","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1067\/mjd.2002.121357","article-title":"Treatment of vitiligo with the 308-nm excimer laser: a pilot study","volume":"46","author":"Spencer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/archderm.138.12.1619","article-title":"Treatment of vitiligo with the 308-nm xenon chloride excimer laser","volume":"138","author":"Baltas","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-4362.2003.01997.x","article-title":"308-nm excimer laser for the treatment of localized vitiligo","volume":"42","author":"Taneja","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2230.2004.01477.x","article-title":"Treatment of vitiligo with the 308 nm excimer laser","volume":"29","author":"Esposito","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lsm.20057","article-title":"Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response","volume":"35","author":"Ostovari","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.det.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archderm.140.8.955","article-title":"The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba","volume":"140","author":"Alexiades-Armenakas","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000065845","article-title":"Repigmentation of vitiligo with topical tacrolimus","volume":"205","author":"Smith","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib23","article-title":"Narrow-band UVB 311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo","author":"Hartmann","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0781.2003.00005.x","article-title":"Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band","volume":"19","author":"Castanedo-Cazares","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.det.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/archderm.140.10.1291","article-title":"Topical tacrolimus and 308 nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1524-4725.2004.30058.x","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawelek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib27","first-page":"37","article-title":"Clinical evaluation of B clear and protopic treatment for vitiligo","volume":"32","author":"Tanghetti","year":"2003","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.det.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003495-200464010-00006","article-title":"Hypopigmentary skin disorders: current treatment options and future directions","volume":"64","author":"Hartmann","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.det.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archderm.134.12.1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib30","first-page":"348","article-title":"Vitiligo: the evolution of cultured epidermal autografts and other surgical treatment modalities","volume":"137","author":"Yaar","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0738-081X(97)00134-X","article-title":"Surgical therapies for vitiligo","volume":"15","author":"Falabella","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib32","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archderm.136.11.1380","article-title":"Treatment of stable vitiligo by timed surgery and transplantation of cultured epidermal autografts","volume":"136","author":"Guerra","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0190-9622(95)90329-1","article-title":"The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation","volume":"33","author":"Westerhof","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0190-9622(95)90131-0","article-title":"The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation","volume":"32","author":"Falabella","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0190-9622(98)70121-5","article-title":"Single hair grafting for the treatment of vitiligo","volume":"38","author":"Na","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archderm.135.11.1305","article-title":"Flip-top pigment transplantation: a novel transplantation procedure for the treatment of depigmentation","volume":"135","author":"McGovern","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0190-9622(92)70024-A","article-title":"Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions","volume":"26","author":"Gauthier","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0140-6736(92)92875-G","article-title":"Melanocyte transplantation in vitiligo","volume":"340","author":"Olsson","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.det.2005.01.001_bib39","first-page":"1341","article-title":"Clinical findings and therapeutic methods in vitiligo: patient's own melanocytes produce new pigmentation","volume":"92","author":"Olsson","year":"1995","journal-title":"Lakartidningen"},{"key":"10.1016\/j.det.2005.01.001_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0190-9622(92)70032-B","article-title":"Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes","volume":"26","author":"Falabella","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/000155598433485","article-title":"Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo","volume":"78","author":"Kaufmann","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2340\/00015555734648","article-title":"Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes","volume":"73","author":"Zachariae","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2340\/0001555574229230","article-title":"Vitiligo: repigmentation with cultured melanocytes after cryostorage","volume":"74","author":"Olsson","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib44","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1524-4725.1989.tb03129.x","article-title":"Micropigmentation for the treatment of vitiligo","volume":"15","author":"Halder","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.det.2005.01.001_bib45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib46","first-page":"163","article-title":"The psychological aspects of vitiligo","volume":"73","author":"Silvan","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.det.2005.01.001_bib47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00128071-200405030-00004","article-title":"Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients","volume":"5","author":"Stratigos","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","article-title":"Mechanism of depigmentation by hydroquinone","volume":"62","author":"Jimbow","year":"1974","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/archderm.1961.01580130137022","article-title":"Hydroquinone bleaching","volume":"84","author":"Spencer","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0738-081X(01)00182-1","article-title":"Depigmenting and bleaching agents: coping with hyperpigmentation","volume":"19","author":"Katsambas","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and instrumental approaches to treat hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.det.2005.01.001_bib53","first-page":"61","article-title":"The study on the efficacy of Rucinol (4-N-butylresorcinol) in chloasma","year":"1999","journal-title":"Nishinihon J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib54","first-page":"11","article-title":"Topically applied 0.3% 4-N-butylresorcinol decrease pigmentation after laser therapy","volume":"9","author":"Akasaka","year":"2002","journal-title":"Environ Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1976.tb05169.x","article-title":"The treatment of hypermelanosis with 4-isopropylcatechol","volume":"94","author":"Bleehen","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib56","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archderm.1991.01680090092011","article-title":"N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma","volume":"127","author":"Jimbow","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib57","first-page":"58","article-title":"Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma","volume":"143","author":"Verallo-Rowell","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.det.2005.01.001_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0536.1995.tb00832.x","article-title":"Contact allergy to kojic acid in skin care products","volume":"32","author":"Nakagawa","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.det.2005.01.001_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(96)90830-0","article-title":"Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo","volume":"34","author":"Kameyama","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000069943","article-title":"A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma","volume":"206","author":"Huh","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2005.01.001_bib61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","article-title":"A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma","volume":"43","author":"Espinal-Perez","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1993.tb03169.x","article-title":"Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial","volume":"129","author":"Griffiths","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial","volume":"130","author":"Kimbrough-Green","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib64","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1056\/NEJM199202063260603","article-title":"Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage","volume":"326","author":"Rafal","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2005.01.001_bib65","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","article-title":"Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients","volume":"328","author":"Bulengo-Ransby","year":"1993","journal-title":"N Engl J Med"},{"issue":"Pt 4","key":"10.1016\/j.det.2005.01.001_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1242\/jcs.107.4.1095","article-title":"Retinoic acid as modulator of UVB-induced melanocyte differentiation: involvement of the melanogenic enzymes expression","volume":"107","author":"Romero","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1016\/j.det.2005.01.001_bib67","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1067\/mjd.2000.107938","article-title":"Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel","volume":"43","author":"Sefton","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2003.451","article-title":"Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial","volume":"49","author":"Kang","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves melasma","volume":"39","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","article-title":"The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation","volume":"11","author":"Yokota","year":"1998","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.det.2005.01.001_bib71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0891-5849(98)00212-3","article-title":"Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line","volume":"26","author":"Saliou","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.det.2005.01.001_bib72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004030050320","article-title":"Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin","volume":"290","author":"Ando","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2005.01.001_bib73","doi-asserted-by":"crossref","first-page":"15427","DOI":"10.1074\/jbc.M313701200","article-title":"Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function","volume":"279","author":"Ando","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.det.2005.01.001_bib74","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma","volume":"72","author":"Taylor","year":"2003","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.det.2005.01.001_bib75","first-page":"261","article-title":"Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2% \/tretinoin 0.01% solution and sunscreen in solar lentigines","volume":"74","author":"Ortonne","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.det.2005.01.001_bib76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(00)90219-6","article-title":"The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies","volume":"42","author":"Fleischer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09546639609089556","article-title":"Combined use of 20% azelaic acid cream and 0.05% tretinoin cream in the topical treatment of melasma","volume":"7","author":"Graupe","year":"1996","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.det.2005.01.001_bib78","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0149-2918(98)80077-5","article-title":"Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone","volume":"20","author":"Kakita","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.det.2005.01.001_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1468-3083.1997.tb00238.x","article-title":"N-acetyl-cysteine as a bleaching agent in the treatment of melasma: a letter to the editor","volume":"9","author":"Njoo","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2005.01.001_bib81","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2133.2003.05161.x","article-title":"Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal","volume":"148","author":"Mahe","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00128071-200001050-00001","article-title":"Management of facial hyperpigmentation","volume":"1","author":"Perez-Bernal","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib83","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1076-0512(98)00109-5","article-title":"Treatment of facial telangiectases with the diode-pumped frequency-doubled Q-switched Nd:YAG laser","volume":"24","author":"Goldberg","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1076-0512(97)82718-5","article-title":"Glycolic acid peels in the treatment of melasma among Asian women","volume":"23","author":"Lim","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002660010107","article-title":"Dermabrasion: a curative treatment for melasma","volume":"25","author":"Kunachak","year":"2001","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.det.2005.01.001_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0733-8635(05)70150-9","article-title":"Disorders of hyperpigmentation","volume":"18","author":"Pandya","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2005.01.001_bib88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archderm.136.7.841","article-title":"A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial","volume":"136","author":"Todd","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/146288300750163745","article-title":"Intense pulsed light source for treatment of small melanocytic nevi and solar lentigines","volume":"2","author":"Bjerning","year":"2000","journal-title":"J Cut Laser Ther"},{"key":"10.1016\/j.det.2005.01.001_bib90","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archderm.136.7.915","article-title":"Laser treatment of pigmented lesions\u20142000: how far have we gone?","volume":"136","author":"Stratigos","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib91","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1524-4725.1999.08171.x","article-title":"Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines","volume":"25","author":"Li","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib92","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","article-title":"Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser","volume":"20","author":"Taylor","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.det.2005.01.001_bib93","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1524-4725.1999.08248.x","article-title":"Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study","volume":"25","author":"Nouri","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1524-4725.1999.08103.x","article-title":"Erbium:YAG laser resurfacing for refractory melasma","volume":"25","author":"Manaloto","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2005.01.001_bib95","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1365-2133.2002.04900.x","article-title":"Cosmetic camouflage advice improves quality of life","volume":"147","author":"Holme","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib96","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0733-8635(05)70209-6","article-title":"Tanning preparations","volume":"18","author":"Levy","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2005.01.001_bib97","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1067\/mjd.2002.119670","article-title":"Medical pearl: DHA application for camouflaging segmental vitiligo and piebald lesions","volume":"47","author":"Suga","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib98","first-page":"177","article-title":"Management of vitiligo patients and attitude of dermatologists towards vitiligo","volume":"14","author":"Ongenae","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2005.01.001_bib99","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.gt.3302264","article-title":"Seeing the gene therapy: application of gene gun technique to transfect and decolour pigmented rat skin with human agouti signalling protein cDNA","volume":"11","author":"Yang","year":"2004","journal-title":"Gene Ther"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863505000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863505000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:03:02Z","timestamp":1706133782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863505000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0733863505000021"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2005.01.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}